Tags Result

October Pharma’s net profits jump 14.2% YoY in Q1 2025

October Pharma logged net profits after tax worth EGP 57.279 million in the first quarter (Q1) of 2025, an annual rise of 14.25% from EGP 50.134 million

Updated 6/2/2025 7:32:00 AM
October Pharma’s profits rise 1.25% YoY in H1

October Pharma (OCPH) reported a net profit after tax of EGP 82.746 million during the first half (H1) of 2024, 1.25% up from EGP 81.722 million in the same half a year earlier.

Updated 8/12/2024 9:28:00 AM
October Pharma posts 20% YoY profit increase in Q1 2024

October Pharma’s (OCPH) net profits after tax surged 20.2% year on year (YoY) during the first quarter (Q1) of 2024.

Updated 5/27/2024 1:00:00 AM
October Pharma to pay 2023 dividend in May

October Pharma will pay cash dividends of EGP 2.5 per share to shareholders for 2023 on May 30th.

Updated 5/12/2024 1:44:00 AM
October Pharma sees 39% YoY profit increase in 2023

October Pharma’s (OCPH) net profits after tax rose by 39.3% year on year in 2023 to EGP 182.132 million, compared to EGP 130.747 million.

Updated 3/10/2024 12:10:00 PM
October Pharma logs 20.1% YoY higher profit in 9 months

October Pharma (OCPH) has reported 20.09% year-on-year (YoY) increase in net profit after tax of EGP 130.739 million during the first nine months of 2023, from EGP 108.864 million in the same period a year earlier.

Updated 11/12/2023 10:39:00 AM
October Pharma’s profits rise 9.9% YoY in H1

The company’s major shareholders include the Arab Company for Drug Industries and Medical Appliances as well as the Saudi-Egyptian Industrial Investment Company.

Updated 8/13/2023 12:37:00 PM
October Pharma’s profits rise 1.8% YoY in Q1

The company’s major shareholders include the Arab Company for Drug Industries and Medical Appliances as well as the Saudi-Egyptian Industrial Investment Company.

Updated 5/29/2023 11:21:00 AM